Skip to main content
. 2021 Sep 16;22(18):10009. doi: 10.3390/ijms221810009

Figure 1.

Figure 1

Nanoparticle-based strategies targeting tumor-associated macrophage in the tumor microenvironment. (A) Depletion of macrophages in tumor tissues; (B) inhibition of monocyte recruitment; (C) reprogramming of M2-type TAM to anti-tumoric M1-type macrophage; and (D) blockade of CD47-Sirpα signaling.